
Vijaypd Ceutical Limited IPO
Vijaypd Ceutical Limited IPO is a SME fixed price IPO. Issue size is 19.25 Cr. Price band is ₹35 per share. Minimum investment is ₹2.80 L. Lot size is 4000 shares. Open from 29 Sept 2025 to 1 Oct 2025. Allotment on 3 Oct 2025. Listing on 7 Oct 2025 at NSE. Managed by Smart Horizon Capital Advisors Pvt.Ltd.. Registrar: Kfin Technologies Limited. Key details for GMP, subscription, price, allotment, and listing in one place.
Official documents:DRHP.
Vijaypd Ceutical Limited IPO overview
Vijaypd Ceutical Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Vijaypd Ceutical Limited IPO important dates
Vijaypd Ceutical Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 8,000 | ₹2,80,000 |
| S-HNI (Min) | 3 | 12,000 | ₹4,20,000 |
| S-HNI (UPI) | 3 | 12,000 | ₹4,20,000 |
| S-HNI (Max) | 7 | 28,000 | ₹9,80,000 |
| B-HNI (Min) | 8 | 32,000 | ₹11,20,000 |
About Vijaypd Ceutical Limited IPO
From the company / RHP narrative.
The company acts as representatives, dealers, agents, stockists, suppliers, traders, and packers.
The company serves the pharmaceutical and wellness industries, as well as the FMCG market, offering products like medicines (injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid oral products), vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items (soaps, sanitizers, baby care), ayurvedic products, cosmetics, food products, dental products, and crude drugs.
As of Marc 31, 2025, the company serves over r 2,109 pharmacies, clinics, and nursing homes across four districts, covering 20 locations.
The company's distribution network connects with over 170 healthcare product manufacturers, providing access to more than 19,000 SKUs.
This product portfolio allows the company to meet customer needs while ensuring quality and reliability in pharmaceutical supply.
The company is a pharmaceutical distributor with FDA, FSSAI, and BMC certifications.
Competitive Strength:
Strengthen its market position by increasing its long-term relationships with its clients.
Comprehensive product portfolio.
Streamlined supply chain management.
Experienced management team with proven execution capabilities.
Objective of the issue
How the issuer plans to use IPO proceeds.
Repayment/prepayment of all or certain of the borrowings availed of by the Company
General corporate purposes
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow IPO & unlisted research in the app, available on iOS and Android.